- Home
- RVSB vs GNTA Comparison
RVSB vs GNTA Comparison
Compare RVSB & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVSB
- GNTA
- Stock Information
- Founded
- RVSB 1923
- GNTA 2014
- Country
- RVSB United States
- GNTA Italy
- Employees
- RVSB N/A
- GNTA N/A
- Industry
- RVSB Savings Institutions
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RVSB Finance
- GNTA Health Care
- Exchange
- RVSB Nasdaq
- GNTA Nasdaq
- Market Cap
- RVSB 110.2M
- GNTA 39.4M
- IPO Year
- RVSB 1993
- GNTA 2021
- Fundamental
- Price
- RVSB $5.25
- GNTA $1.96
- Analyst Decision
- RVSB Buy
- GNTA
- Analyst Count
- RVSB 1
- GNTA 0
- Target Price
- RVSB $7.00
- GNTA N/A
- AVG Volume (30 Days)
- RVSB 46.7K
- GNTA 185.8K
- Earning Date
- RVSB 10-28-2025
- GNTA 01-01-0001
- Dividend Yield
- RVSB 1.52%
- GNTA N/A
- EPS Growth
- RVSB 361.12
- GNTA N/A
- EPS
- RVSB 0.22
- GNTA N/A
- Revenue
- RVSB $52,756,000.00
- GNTA N/A
- Revenue This Year
- RVSB $10.25
- GNTA N/A
- Revenue Next Year
- RVSB $11.23
- GNTA N/A
- P/E Ratio
- RVSB $23.91
- GNTA N/A
- Revenue Growth
- RVSB 15.20
- GNTA N/A
- 52 Week Low
- RVSB $4.74
- GNTA $1.35
- 52 Week High
- RVSB $6.59
- GNTA $10.00
- Technical
- Relative Strength Index (RSI)
- RVSB 51.54
- GNTA 41.66
- Support Level
- RVSB $5.05
- GNTA $1.35
- Resistance Level
- RVSB $5.34
- GNTA $2.32
- Average True Range (ATR)
- RVSB 0.14
- GNTA 0.23
- MACD
- RVSB -0.01
- GNTA 0.00
- Stochastic Oscillator
- RVSB 40.01
- GNTA 53.57
About RVSB Riverview Bancorp Inc
Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.